InduRATE
- Emma Turner
- Mark Schuweiler
- Ishir Sharma
- Amanda Cheung
- Sabrina Zhou
- Mads Bundgaard Nørløv
- Dr. Youseph Yazdi, PhD, MBA
- Dr. Soumyadipta Acharya, MD, MSE, PhD
- Dr. Amita Gupta
- Dr. Samyra Cox
- Dr. Meghashish Sharma
- Neetisha Besra
Abstract:
Our team has partnered with GKII to enhance Latent Tuberculosis Infection (LTBI) screening protocols in India. Over the summer, we conducted ethnographic research in India to gain insights into the tuberculosis landscape. Current protocols require patients to return to the clinic 2-3 days after their initial visit, where a clinician measures the induration of a skin test (Cy-Tb) using a ruler. This process is time-consuming and limits screening capacity. Based on our findings, we identified a critical need for an accurate, home-based method to measure Cy-Tb test results, eliminating the need for repeat visits and streamlining the screening process. To address this, our team has spent the past year developing a scalable, low-cost medical device aimed at improving LTBI screening efficiency and accessibility in resource-limited settings.